How this receipt has changed
Potential factors for the difference in contrast-induced nephropathy risk between intra-arterial and intravenous administration include contrast volume, patient hemodynamic stability, and the risk of atheroemboli.
This receipt has not been rewritten since it was published on 03 Oct 2026. Its current version is 1.
Weight is the one the receipt's balance bar uses: every source counts 1, plus a bounded bonus for how often it has been cited, so one famous paper cannot outweigh three dissenting ones (at most 3x a bare source). It is a reading aid built from facts the receipt already stores, not the engine's confidence.
The same numbers as a table
| Version | Verdict | For | Against | Weight for | Weight against | From |
|---|---|---|---|---|---|---|
| v1 | SUPPORTED | 2 | 0 | 2.05 | 0 | 2026-10-03 |
Every version
- Version 1 (current)in effect since 03 Oct 2026SUPPORTED2 for, 0 against · confidence 78